Indexperts Gorilla激进成长主动型ETF RILA 深 沪
等待开盘 02-20 09:30:00 美东时间
11.02
+0.001
+0.01%
华盛通- 最 高11.02
- 今 开10.97
- 成交量 7126股
- 最 低 10.93
- 昨 收 11.0187
- 总市值 4085.13万
- 52周最高 12.1362
- 市盈率 静 --
- 换手率 0.19%
- 52周最低 8.6142
- 委 比 0.00%
- 总股本 370.70万
- 历史最高 12.1362
- 量 比 1.01
- 振 幅 0.82%
- 历史最低 8.6142
- 每 手 1
- 风险率 0.80%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多The $461B Boom That Advisors Can't Ignore
Stock market up, tech and AI lead. Annuities shatter records for 4th year, driven by demand for guarantees in volatile market. Boomers and Gen X interested.
02-16 00:01
Corebridge meldet für das Gesamtjahr 2025 eine Kapitalrückführung an Aktionäre von 2,6 Mrd. USD, ein Plus von 13 Prozent
Corebridge meldet für das Gesamtjahr 2025 eine Kapitalrückführung an Aktionäre von 2,6 Mrd. USD, ein Plus von 13 Prozent Corebridge Financial meldet für das Gesamtjahr 2025 einen operativen Gewinn je Aktie von USD 4,42, was einem Anstieg von 4 Prozent gegenüber dem Vorjahr entspricht. Die bereinigte
02-10 05:16
Corebridge Financial Q4 net flows drop 62% to USD 641 million
Corebridge Financial Q4 net flows drop 62% to USD 641 million Corebridge Financial reported its fourth quarter (Q4) and full year (FY) 2025 results, posting an operating EPS of 4.42 for FY 2025, up 4% year over year (YoY). Adjusted ROAE reached 11.5%, an increase of 0.2 percentage points YoY. The co
02-10 05:16
BRIEF-Reviva Announces Regulatory Update Regarding The Development Of Brilaroxazine For The Treatment Of Schizophrenia
Dec 23 (Reuters) - Reviva Pharmaceuticals Holdings Inc RVPH.O: REVIVA ANNOUNCES REGULATORY UPDATE REGARDING THE DEVELOPMENT OF BRILAROXAZINE FOR THE TREATMENT OF SCHIZOPHRENIA REVIVA PHARMACEUTICALS H...
2025-12-23 21:19
BRIEF-Reviva Pharmaceuticals Recover-2 Trial Projected To Cost About $60 Million
Dec 23 (Reuters) - Reviva Pharmaceuticals Holdings Inc RVPH.O: REVIVA PHARMACEUTICALS: RECOVER-2 TRIAL PROJECTED TO COST ABOUT $60 MILLION REVIVA PHARMACEUTICALS: MAY INITIATE PHASE 3 TRIAL OF BRILARO...
2025-12-23 21:10
Jackson Financial Q3 adjusted operating earnings rise
Overview Jackson Financial Q3 adjusted operating earnings rise to $433 mln, reflecting higher spread income Retail annuity sales grow 2% yr/yr, driven by strong demand for variable and RILA products I...
2025-11-05 05:23
BRIEF-Cadre Holdings-On Oct 28, Co & Unit Enters Securities Purchase Agreement With Rg Beck Az - SEC Filing
Nov 4 (Reuters) - Cadre Holdings Inc CDRE.N: CADRE HOLDINGS-ON OCT 28, CO & UNIT ENTERS SECURITIES PURCHASE AGREEMENT WITH RG BECK AZ - SEC FILING CADRE HOLDINGS INC - SAFARILAND, LLC TO BUY EQUITY FO...
2025-11-04 07:29
Corebridge Financial posts Q3 net income on rise in premiums, deposits
Overview Corebridge Q3 net income of $144 mln, reversing a loss from prior year Adjusted after-tax operating income fell 28% due to actuarial updates Premiums and deposits rose 34% yr/yr, driven by an...
2025-11-04 05:41
Corebridge Financial Q2 2025: Net Loss of $660M vs $365M Gain YOY, EPS Down to $(1.20), Premiums & Deposits Drop 7%
Corebridge Financial Inc. (NYSE: CRBG) announced its financial results for the second quarter ended June 30, 2025. The company reported a net loss of $660 million, contrasting with a gain of $365 mill...
2025-08-05 04:16
